BridgeMD
New treatment option for Brain Tumors
Official title SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
ClinicalTrials.gov ID: NCT06878469
What this study is testing
- What it's testing
- This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (age ≥18 years)
- Both sexes
- Patients with rare brain tumors (incidence \<6 cases per 100,000 people/year)
- Candidates for craniotomy for rare brain tumors
- Native Italian speakers for cognitive and psychological evaluation and neuro-cognitive rehabilitation
You likely can't join if
- Patients undergoing stereotactic/frameless biopsy
- Patients with psychiatric disorders or on psychotropic medications
- Patients with known cognitive decline (not due to the lesion)
- Patients admitted on the same day as the surgery
- Patients with severe impairments referred to rehabilitation centers
- Patients without a Windows PC or laptop with Internet connection for neuro-cognitive rehabilitation
The study team makes the final eligibility decision.
Where it's taking place
- Milan, PA, Italy
- L’Aquila, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, PA, Italy; L’Aquila, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.